All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation;Eagle;Neuromuscul Disord,2002
2. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade;Biggar;Neuromuscul Disord,2006
3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol,2010
4. Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy;Gilroy;Circulation,1963
5. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy;Melacini;Neuromuscul Disord,1996
Cited by 158 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy;Birth Defects Research;2023-10-18
2. Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy;Neurotherapeutics;2023-10
3. Real world respiratory profiles and Duchenne muscular dystrophy;Pediatric Pulmonology;2023-09-22
4. Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy;Circulation: Heart Failure;2023-08
5. Consensus concept of modern effective therapy for Duchenne muscular dystrophy;Neuromuscular Diseases;2023-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3